---
reference_id: "PMID:29795570"
title: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.
authors:
- Rivas MA
- Avila BE
- Koskela J
- Huang H
- Stevens C
- Pirinen M
- Haritunians T
- Neale BM
- Kurki M
- Ganna A
- Graham D
- Glaser B
- Peter I
- Atzmon G
- Barzilai N
- Levine AP
- Schiff E
- Pontikos N
- Weisburd B
- Lek M
- Karczewski KJ
- Bloom J
- Minikel EV
- Petersen BS
- Beaugerie L
- Seksik P
- Cosnes J
- Schreiber S
- Bokemeyer B
- Bethge J
- International IBD Genetics Consortium
- NIDDK IBD Genetics Consortium
- T2D-GENES Consortium
- Heap G
- Ahmad T
- Plagnol V
- Segal AW
- Targan S
- Turner D
- Saavalainen P
- Farkkila M
- Kontula K
- Palotie A
- Brant SR
- Duerr RH
- Silverberg MS
- Rioux JD
- Weersma RK
- Franke A
- Jostins L
- Anderson CA
- Barrett JC
- MacArthur DG
- Jalas C
- Sokol H
- Xavier RJ
- Pulver A
- Cho JH
- McGovern DPB
- Daly MJ
journal: PLoS Genet
year: '2018'
doi: 10.1371/journal.pgen.1007329
content_type: abstract_only
---

# Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.
**Authors:** Rivas MA, Avila BE, Koskela J, Huang H, Stevens C, Pirinen M, Haritunians T, Neale BM, Kurki M, Ganna A, Graham D, Glaser B, Peter I, Atzmon G, Barzilai N, Levine AP, Schiff E, Pontikos N, Weisburd B, Lek M, Karczewski KJ, Bloom J, Minikel EV, Petersen BS, Beaugerie L, Seksik P, Cosnes J, Schreiber S, Bokemeyer B, Bethge J, International IBD Genetics Consortium, NIDDK IBD Genetics Consortium, T2D-GENES Consortium, Heap G, Ahmad T, Plagnol V, Segal AW, Targan S, Turner D, Saavalainen P, Farkkila M, Kontula K, Palotie A, Brant SR, Duerr RH, Silverberg MS, Rioux JD, Weersma RK, Franke A, Jostins L, Anderson CA, Barrett JC, MacArthur DG, Jalas C, Sokol H, Xavier RJ, Pulver A, Cho JH, McGovern DPB, Daly MJ
**Journal:** PLoS Genet (2018)
**DOI:** [10.1371/journal.pgen.1007329](https://doi.org/10.1371/journal.pgen.1007329)

## Content

1. PLoS Genet. 2018 May 24;14(5):e1007329. doi: 10.1371/journal.pgen.1007329. 
eCollection 2018 May.

Insights into the genetic epidemiology of Crohn's and rare diseases in the 
Ashkenazi Jewish population.

Rivas MA(1)(2), Avila BE(1)(3), Koskela J(1)(3)(4), Huang H(1)(3), Stevens C(1), 
Pirinen M(4)(5), Haritunians T(6), Neale BM(1)(3), Kurki M(1)(3), Ganna A(1)(3), 
Graham D(1), Glaser B(7), Peter I(8), Atzmon G(9)(10), Barzilai N(9), Levine 
AP(11), Schiff E(11), Pontikos N(11)(12), Weisburd B(1)(3), Lek M(1)(3), 
Karczewski KJ(1)(3), Bloom J(1)(3), Minikel EV(1)(3), Petersen BS(13), Beaugerie 
L(14), Seksik P(14), Cosnes J(14), Schreiber S(15), Bokemeyer B(16), Bethge 
J(15); International IBD Genetics Consortium; NIDDK IBD Genetics Consortium; 
T2D-GENES Consortium; Heap G(17), Ahmad T(18), Plagnol V(12), Segal AW(11), 
Targan S(6), Turner D(19), Saavalainen P(20), Farkkila M(21), Kontula K(22), 
Palotie A(1)(4)(23), Brant SR(24)(25), Duerr RH(26)(27), Silverberg MS(28), 
Rioux JD(29)(30), Weersma RK(31), Franke A(13), Jostins L(32), Anderson CA(33), 
Barrett JC(33), MacArthur DG(1)(3), Jalas C(34), Sokol H(14), Xavier RJ(1)(35), 
Pulver A(36), Cho JH(37), McGovern DPB(6), Daly MJ(1)(3)(4).

Collaborators: Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, 
Andersen V, Anderson CA, Andrews JM, Annese V, Aumais G, Baidoo L, Baldassano 
RN, Bampton PA, Barclay M, Barrett JC, Bayless TM, Bethge J, Bitton A, Boucher 
G, Brand S, Brandt B, Brant SR, Büning C, Chew A, Cho JH, Cleynen I, Cohain A, 
Croft A, Daly MJ, D'Amato M, Danese S, De Jong D, De Vos M, Denapiene G, Denson 
LA, Devaney KL, Dewit O, D'Inca R, Dubinsky M, Duerr RH, Edwards C, Ellinghaus 
D, Essers J, Ferguson LR, Festen EA, Fleshner P, Florin T, Franchimont D, Franke 
A, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Goyette P, Green T, 
Griffiths AM, Guthery SL, Hakonarson H, Halfvarson J, Hanigan K, Haritunians T, 
Hart A, Hawkey C, Hayward NK, Hedl M, Henderson P, Hu X, Huang H, Hugot JP, Hui 
KY, Imielinski M, Ippoliti A, Jonaitis L, Jostins L, Karlsen TH, Kennedy NA, 
Khan MA, Kiudelis G, Krishnaprasad K, Kugathasan S, Kupcinskas L, Latiano A, 
Laukens D, Lawrance IC, Lee JC, Lees CW, Leja M, Van Limbergen J, Lionetti P, 
Liu JZ, Louis E, Mahy G, Mansfield J, Massey D, Mathew CG, McGovern DP, Milgrom 
R, Mitrovic M, Montgomery GW, Mowat C, Newman W, Ng A, Ng SC, Ng SME, Nikolaus 
S, Ning K, Nöthen M, Oikonomou I, Palmieri O, Parkes M, Phillips A, Ponsioen CY, 
Potocnik U, Prescott NJ, Proctor DD, Radford-Smith G, Rahier JF, Raychaudhuri S, 
Regueiro M, Rieder F, Rioux JD, Ripke S, Roberts R, Russell RK, Sanderson JD, 
Sans M, Satsangi J, Schadt EE, Schreiber S, Schulte D, Schumm LP, Scott R, 
Seielstad M, Sharma Y, Silverberg MS, Simms LA, Skieceviciene J, Spain SL, 
Steinhart AH, Stempak JM, Stronati L, Sventoraityte J, Targan SR, Taylor KM, Ter 
Velde A, Theatre E, Torkvist L, Tremelling M, van der Meulen A, van Sommeren S, 
Vasiliauskas E, Vermeire S, Verspaget HW, Walters T, Wang K, Wang MH, Weersma 
RK, Wei Z, Whiteman D, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zhang B, 
Zhang CK, Zhang H, Zhang W, Zhao H, Zhao ZZ, Abraham C, Achkar JP, Bitton A, 
Boucher G, Croitoru K, Fleshner P, Kugathasan S, Limbergen JV, Milgrom R, 
Proctor D, Regueiro M, Schumm PL, Sharma Y, Stempak JM, Targan SR, Wang MH, 
Fuchsberger C, Flannick J, Teslovich TM, Mahajan A, Agarwala V, Gaulton KJ, Ma 
C, Fontanillas P, Moutsianas L, McCarthy DJ, Rivas MA, Perry JRB, Sim X, 
Blackwell TW, Robertson NR, Rayner W, Cingolani P, Locke AE, Tajes JF, Highland 
HM, Dupuis J, Chines PS, Lindgren CM, Hartl C, Jackson AU, Chen H, Huyghe JR, 
van de Bunt M, Pearson RD, Kumar A, Müller-Nurasyid M, Grarup N, Stringham HM, 
Gamazon ER, Lee J, Chen Y, Scott RA, Below JE, Chen P, Huang J, Go MJ, Stitzel 
ML, Pasko D, Parker SCJ, Varga TV, Green T, Beer NL, Williams AGD, Ferreira T, 
Fingerlin T, Horikoshi M, Hu C, Huh I, Ikram MK, Kim BJ, Kim Y, Kim YJ, Kwon MS, 
Lee J, Lee S, Lin KH, Maxwell TJ, Nagai Y, Wang X, Welch RP, Yoon J, Zhang W, 
Barzilai N, Voight BF, Han BG, Jenkinson CP, Kuulasmaa T, Kuusisto J, Manning A, 
Ng MCY, Palmer ND, Balkau B, Stančáková A, Abboud HE, Boeing H, Giedraitis V, 
Prabhakaran D, Gottesman O, Scott J, Carey J, Kwan P, Grant G, Smith JD, Neale 
BM, Purcell S, Butterworth AS, Howson JM, Lee HM, Lu Y, Kwak SH, Zhao W, Danesh 
J, Lam VKL, Park KS, Saleheen D, So WY, Tam CHT, Afzal U, Aguilar D, Arya R, 
Aung T, Chan E, Navarro C, Cheng CY, Palli D, Correa A, Curran JE, Rybin D, 
Farook VS, Fowler SP, Freedman BI, Griswold M, Hale DE, Hicks PJ, Khor CC, Kumar 
S, Lehne B, Thuillier D, Lim WY, Liu J, van der Schouw YT, Loh M, Musani SK, 
Puppala S, Scott WR, Yengo L, Tan ST, Taylor HA Jr, Thameem F, Wilson G Sr, Wong 
TY, Njølstad PR, Levy JC, Mangino M, Bonnycastle LL, Schwarzmayr T, Fadista J, 
Surdulescu GL, Herder C, Groves CJ, Wieland T, Jensen JB, Brandslund I, 
Christensen C, Koistinen HA, Doney ASF, Kinnunen L, Esko T, Farmer AJ, Hakaste 
L, Hodgkiss D, Kravic J, Lyssenko V, Hollensted M, Jørgensen ME, Jørgensen T, 
Ladenvall C, Justesen JM, Käräjämäki A, Kriebel J, Rathmann W, Lannfelt L, 
Lauritzen T, Narisu N, Linneberg A, Melander O, Milani L, Neville M, Melander 
MO, Qi L, Qi Q, Roden M, Rolandsson O, Swift A, Rosengren AH, Stirrups K, Wood 
AR, Mihailov E, Blancher C, Carneiro MO, Maguire J, Poplin R, Shakir K, Fennell 
T, DePristo M, de Angelis MH, Deloukas P, Gjesing AP, Jun G, Nilsson P, Murphy 
J, Onofrio R, Thorand B, Hansen T, Meisinger C, Hu FB, Isomaa B, Karpe F, Liang 
L, Peters A, Huth C, O'Rahilly SP, Palmer CNA, Pedersen O, Rauramaa R, 
Tuomilehto J, Salomaa V, Watanabe RM, Syvänen AC, Bergman RN, Bharadwaj D, 
Bottinger EP, Cho YS, Chandak GR, Chan JCN, Chia KS, Daly MJ, Ebrahim SB, 
Langenberg C, Elliott P, Jablonski KA, Lehman DM, Jia W, Ma RCW, Pollin TI, 
Sandhu M, Tandon N, Froguel P, Barroso I, Teo YY, Zeggini E, Loos RJF, Small KS, 
Ried JS, DeFronzo RA, Grallert H, Glaser B, Metspalu A, Wareham NJ, Walker M, 
Banks E, Gieger C, Ingelsson E, Im HK, Illig T, Franks PW, Buck G, Trakalo J, 
Buck D, Prokopenko I, Mägi R, Lind L, Farjoun Y, Owen KR, Gloyn AL, Strauch K, 
Tuomi T, Kooner JS, Lee JY, Park T, Donnelly P, Morris AD, Hattersley AT, Bowden 
DW, Collins FS, Atzmon G, Chambers JC, Spector TD, Laakso M, Strom TM, Bell GI, 
Blangero J, Duggirala R, Tai ES, McVean G, Hanis CL, Wilson JG, Seielstad M, 
Frayling TM, Meigs JB, Cox NJ, Sladek R, Lander ES, Gabriel S, Burtt NP, Mohlke 
KL, Meitinger T, Groop L, Abecasis G, Florez JC, Scott LJ, Morris AP, Kang HM, 
Boehnke M, Altshuler D, McCarthy MI.

Author information:
(1)Medical and Population Genetics, Broad Institute, Cambridge, MA, United 
States of America.
(2)Department of Biomedical Data Science, Stanford University, Stanford, CA, 
United States of America.
(3)Analytical and Translational Genetics Unit, Massachusetts General Hospital, 
Boston, MA, United States of America.
(4)Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 
Helsinki, Finland.
(5)Department of Mathematics and Statistics, University of Helsinki, Helsinki, 
Finland.
(6)Translational Genomics Unit, F. Widjaja Foundation Inflammatory Bowel and 
Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 
United States of America.
(7)Hadassah-Hebrew University Medical Center, Endocrinology and Metabolism 
Service Department of Internal Medicine, Jerusalem, Israel.
(8)Department of Genetics and Genomic Sciences, Icahn School of Medicine at 
Mount Sinai, New York, NY, United States of America.
(9)Department of Genetics and Medicine, Albert Einstein College of Medicine, 
Bronx, NY, United States of America.
(10)Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
(11)Division of Medicine, University College London, London, United Kingdom.
(12)UCL Genetics Institute, University College London, London, United Kingdom.
(13)Institute of Clinical Molecular Biology, Christian-Albrechts-University of 
Kiel, Kiel, Germany.
(14)Gastroenterology Department, Saint-Antoine Hospital, AP-HP, UPMC Univ Paris, 
Paris, France.
(15)Department of Internal Medicine, University Hospital Schleswig-Holstein, 
Kiel, Germany.
(16)Gastroenterology Practice, Minden, Germany.
(17)IBD Pharmacogenetics, Royal Devon and Exeter NHS Trust, Exeter, United 
Kingdom.
(18)Peninsula College of Medicine and Dentistry, Exeter, United Kingdom.
(19)Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Shaare 
Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.
(20)Research Programs Unit, Immunobiology, and Department of Medical and 
Clinical Genetics, University of Helsinki, Helsinki, Finland.
(21)Department of Medicine, Division of Gastroenterology, Helsinki University 
Hospital, Helsinki, Finland.
(22)Department of Medicine, University of Helsinki and Helsinki University 
Central Hospital, Helsinki, Finland.
(23)Department of Neurology, Massachusetts General Hospital, Boston, MA, United 
States of America.
(24)Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, School 
of Medicine, Johns Hopkins University, Baltimore, MD, United States of America.
(25)Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins 
University, Baltimore, MD, United States of America.
(26)Division of Gastroenterology, Hepatology and Nutrition, Department of 
Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United 
States of America.
(27)Department of Human Genetics, University of Pittsburgh Graduate School of 
Public Health, Pittsburgh, PA, United States of America.
(28)Inflammatory Bowel Disease Centre, Mount Sinai Hospital, Toronto, Ontario, 
Canada.
(29)Research Center, Montreal Heart Institute, Montréal, Québec, Canada.
(30)Department of Medicine, Université de Montréal, Montréal, Québec, Canada.
(31)Department of Gastroenterology and Hepatology, University Medical Center 
Groningen, Groningen, The Netherlands.
(32)Wellcome Trust Centre for Human Genetics, Oxford University, Oxford, United 
Kingdom.
(33)Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, 
United Kingdom.
(34)Bonei Olam, Center for Rare Jewish Genetic Disorders, Brooklyn, NY, United 
States of America.
(35)Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease 
and Center for Computational and Integrative Biology, Massachusetts General 
Hospital, Harvard Medical School, Boston, MA, United States of America.
(36)Department of Psychiatry and Behavioral Sciences, Johns Hopkins University 
School of Medicine, Baltimore, MD, United States of America.
(37)Icahn School of Medicine at Mount Sinai, Dr Henry D. Janowitz Division of 
Gastroenterology, New York, NY, United States of America.

Erratum in
    PLoS Genet. 2019 May 30;15(5):e1008190. doi: 10.1371/journal.pgen.1008190.

As part of a broader collaborative network of exome sequencing studies, we 
developed a jointly called data set of 5,685 Ashkenazi Jewish exomes. We make 
publicly available a resource of site and allele frequencies, which should serve 
as a reference for medical genetics in the Ashkenazim (hosted in part at 
https://ibd.broadinstitute.org, also available in gnomAD at 
http://gnomad.broadinstitute.org). We estimate that 34% of protein-coding 
alleles present in the Ashkenazi Jewish population at frequencies greater than 
0.2% are significantly more frequent (mean 15-fold) than their maximum frequency 
observed in other reference populations. Arising via a well-described founder 
effect approximately 30 generations ago, this catalog of enriched alleles can 
contribute to differences in genetic risk and overall prevalence of diseases 
between populations. As validation we document 148 AJ enriched protein-altering 
alleles that overlap with "pathogenic" ClinVar alleles (table available at 
https://github.com/macarthur-lab/clinvar/blob/master/output/clinvar.tsv), 
including those that account for 10-100 fold differences in prevalence between 
AJ and non-AJ populations of some rare diseases, especially recessive 
conditions, including Gaucher disease (GBA, p.Asn409Ser, 8-fold enrichment); 
Canavan disease (ASPA, p.Glu285Ala, 12-fold enrichment); and Tay-Sachs disease 
(HEXA, c.1421+1G>C, 27-fold enrichment; p.Tyr427IlefsTer5, 12-fold enrichment). 
We next sought to use this catalog, of well-established relevance to Mendelian 
disease, to explore Crohn's disease, a common disease with an estimated two to 
four-fold excess prevalence in AJ. We specifically attempt to evaluate whether 
strong acting rare alleles, particularly protein-truncating or otherwise large 
effect-size alleles, enriched by the same founder-effect, contribute excess 
genetic risk to Crohn's disease in AJ, and find that ten rare genetic risk 
factors in NOD2 and LRRK2 are enriched in AJ (p < 0.005), including several 
novel contributing alleles, show evidence of association to CD. Independently, 
we find that genomewide common variant risk defined by GWAS shows a strong 
difference between AJ and non-AJ European control population samples (0.97 s.d. 
higher, p<10-16). Taken together, the results suggest coordinated selection in 
AJ population for higher CD risk alleles in general. The results and approach 
illustrate the value of exome sequencing data in case-control studies along with 
reference data sets like ExAC (sites VCF available via FTP at 
ftp.broadinstitute.org/pub/ExAC_release/release0.3/) to pinpoint genetic 
variation that contributes to variable disease predisposition across 
populations.

DOI: 10.1371/journal.pgen.1007329
PMCID: PMC5967709
PMID: 29795570 [Indexed for MEDLINE]

Conflict of interest statement: The authors have declared that no competing 
interests exist.